Report from the Infectious Diseases Summit

Accordia Global Health Foundation and the Infectious Diseases Institute co-hosted the second annual Accordia Infectious Diseases Summit April 20-22 in Kampala, Uganda. The invitation-only event brought together global leaders in academia, government, NGOs, and industry and featured a key note address by the First Lady of Uganda.

The theme of this year’s Summit was "Building Healthcare Leadership in Africa," and focused on ways to build a strong and sustainable healthcare leadership infrastructure in Africa. Over 100 representatives from 21 countries attended.

A shift from short-term to long-term strategies

For the past several years, the world’s attention has focused on the need to arrest and reverse the growing healthcare crisis in Africa, where millions of men, women, and children are infected with or
"Africa should serve as a shining example of health leadership as a model for the rest of world."

– Prof. Nelson Sewankambo
suffering as a result of infectious diseases like HIV/AIDS, malaria, and tuberculosis. However, the vast majority of efforts have been directed towards short-term projects. These are critical components in the fight against infectious diseases, but they do not address the long-terms needs of sub-Saharan Africa for a healthcare system that can effectively diagnose and treat the illnesses of today and those which may appear in the future.

Building leadership through individuals, institutions and networks

The Summit addressed the challenges and opportunities of building health leadership at three levels: individual, institutional, and networks. It featured personal perspectives from students, faculty, and patient advocates about their own experiences building leadership and management competencies as well as input from respected thought-leaders in the field. It examined successful leadership development programs and leading centers of excellence, considered the impact of culture on the attributes of effective leaders, and discussed the need for effective collaborative leadership across nations, regions, and the African continent.

A call to action

Following two days of dynamic discussions and presentations, Summit participants developed a call to action and urged an investment in leaders and leadership development at all levels. Participants recognized that institutions must be more deliberate about strategies to identify, retain, and nurture talent, including the development of accountable and transparent management structures; mentorship and evaluation approaches that provide young leaders the opportunity to lead and the incentive to take risks; and systems and policies that empower effective leadership. Looking to the future, Africa’s leading medical schools and research institutes are encouraged to work more closely with patient advocacy groups and health ministries to link organizational priorities to the greatest needs of society and to develop better tools to measure the critical impact of leading institutions on health outcomes. Finally, the global community is urged to work within existing institutions to develop leadership capacity that is focused on long-term strategies and rooted in practical realities and to provide core funding to support the cost of excellence within these institutions.

In June, Accordia will release a report informed by the Infectious Diseases Summit that includes an in depth look at the three Summit tracks and explores ways in which their interconnectivity could drive unique opportunities to expand the impact of healthcare leadership in Africa.

Click here to view photographs from the 2009 Summit.

TOP

Many Thanks to Our Summit Sponsors

ORGANIZING PARTNER

Pfizer

SPONSORING PARTNERS

AstraZeneca
Bayer Healthcare
Bristol-Myers Squibb

LEADERSHIP PARTNERS

The Bill & Melinda Gates Foundation
Merck
National Institutes of Health, Office of AIDS Research
Schering-Plough Foundation

SUPPORTING PARTNERS

Almirall
BD


"Every day 6,000 children will lose a parent to AIDS. At the Infectious Diseases Institute, we are not only treating patients, we are saving families. Over 8,000 mothers, fathers, and family
members are receiving lifesaving antiretroviral therapy through IDI. IDI’s
research, training and clinical care programs are focused on creating a new generation in sub-Saharan Africa free from the burden of infectious diseases."


J. Moses Ceaser Photography
TOP


Accordia believes that building healthcare leadership capacity in Africa is
essential to overcome the burden of infectious diseases such as HIV/AIDS,
malaria and tuberculosis. At the Accordia Infectious Diseases Summit 2009, which we co-hosted with the Infectious Diseases Institute in Uganda in April, it became evident that there is strong global interest in this topic. The Summit was a high-energy meeting that explored development of a new generation of healthcare leadership in Africa through cross-sector initiatives aimed at individuals, institutions and networks.

Focusing on permanent solutions

Summit participants agreed that a long-term solution to the healthcare crisis in Africa requires first class leadership and solid management. Nascent leadership programs are beginning to spring up in many parts of Africa and we heard from many participants about new, innovative approaches to facilitate growth in this area.

Advancing leadership development in Africa

In June, Accordia will release a publication informed by the Summit with specific recommendations for advancing leadership development in Africa. Contributors to this report include thought-leaders from academia, government, NGOs and industry who bring their own expertise in building leadership and management competencies.

Join us as we change the course of human history

In addition to the Summit, Accordia continues to strengthen our core programs at IDI. The best practices and models of care and training being established at IDI have proven to have far-reaching impact, as many programs have begun to be adopted at the national and regional level. We continue to be proud of and inspired by IDI’s many contributions.

Accordia’s programs are made possible because of the support of our friends and generous donors. Please consider making a commitment to Accordia and the work we are doing in sub-Saharan Africa. Visit www.accordiafoundation.org to discover how you can support our efforts today.


  President, Accordia Global Health Foundation

TOP

Strengthening Training Capacity in Nigeria

In February, IDI hosted a group of twenty top infectious disease specialists from Nigeria for a 3-week customized course designed to help participants hone their training and program management skills, update the Nigerian national ART training curriculum, and further define the vision for a West African Infectious Diseases Institute. The course was a critical element of a public-private partnership between ExxonMobil and PEPFAR Nigeria, in which Accordia and IDI both play major roles.

The physicians who attended this customized "Master Trainers Course" took time away from their leadership posts within government, universities, and other training organizations throughout Nigeria to spend uninterrupted time with their Ugandan colleagues and IDI’s management and training teams. The first week of the course was a Program Management module, part of a new collection of course offerings at IDI but tailored for the Nigerian participants’ specific needs and focused on the concept of a West African Infectious Diseases Institute modeled on Makerere’s IDI. Week Two took the participants through IDI’s new Advanced ART module for physicians with prior training in ART management.

The final week was devoted to building training skills among the participants — a "Train the Trainers" module focused on curriculum development skills and new approaches to adult education. As part of this training, participants were asked to "refresh" Nigeria’s national ART training curriculum. New national guidelines were incorporated into the revised curriculum, and a course outline and comprehensive set of lectures were collaboratively created. Each of the Nigerian "Master Trainers" will go on to train other Advanced Qualified Trainers in Nigeria as part of this important collaboration to build national training capacity.TOP

 

IDI Trainee Improves HIV Care in Local

"There are many poor people here who survive on less than two dollars a day. We treat quite a few soldiers and most of our patients are women, widows and children who fear disclosure. There remains a huge stigma in our community where women hide their medication underneath their baskets. We are their only hope."

"Compassion and kindness," she said. Three
simple words softly spoken. Yet, powerful
and clear. It wasn’t a statement necessarily about herself, but a response to the question: "What does it take to be an effective healthcare worker in the HIV community in Africa?" Brilliance, to understand an incredibly complex and debilitating disease with equally challenging drug regimens? Mental toughness, to endure the heartbreaking stories undoubtedly communicated on a daily basis by patients? Optimism? No. Compassion and kindness. The response itself spoke volumes about Dr. Olivia Kharono, a clinical officer at the Joint Clinical Research Center (JCRC) in Mubende who recently completed training in advanced HIV/AIDS care and prevention at the Infectious Diseases Institute in Kampala.

Improving Patient Care through Training

Since graduating from Fort Portal School of Clinical Officers in 2005, Dr. Kharono has worked in areas heavily impacted by HIV/AIDS. Clinical officers, nurses and other mid-level practitioners are increasingly taking on tasks conventionally assigned to doctors, as they outnumber them by 6:1 in these settings. Recognizing the need to increase her skill set and better address the needs of her patients, Dr. Kharono sought out training at the Infectious Disease Institute in 2008. IDI was one of the first training centers to offer training in advanced HIV/AIDS care and prevention to clinical officers. "There were several reasons both personally and professionally I chose to attend IDI. First, I wanted to improve the quality of life for my patients. I also wanted to perfect my clinical skills by learning drug regimens and toxicities in order to prescribe medicine. Because of IDI, I do that now for my patients and am a more effective practitioner."

A Holistic Approach to Treatment

In a clinic like JCRC, Mubende, which treats over 6,383 patients and has initiated ART for over 1,652 of them, more trained professionals improves the quality of the clinic overall. "At IDI, I learned to really take time with patients; to put down the pen and really listen. And I have used the training to pass on information to my colleagues. We are task-shifting what we know to others so we can manage more activities. In that way, the whole health center improves."TOP


Drama Group Supports Prevention
Activities at IDI

Charles Kasumba, the Music, Dance & Drama Trainer at IDI,
Above: Charles Kasumba, the Music, Dance & Drama Trainer at IDI, rehearses with the MD&D group before a local performance. (Photography by Charles Steinberg)

The Creativity Initiative at the Infectious Diseases Institute is a patient-led initiative designed to build a network of care supporters and volunteers who promote adherence to HIV treatment and help members gain entrepreneurial skills to enable them to become self-sufficient. A critical component of the Creativity Initiative is its strong, professional drama group. The group’s members work to help their audiences develop an understanding of the issues related to HIV/AIDS, support prevention activities, and help reduce the stigma that so many infected individuals and their families encounter.

Reaching out to the local community

The IDI Music, Dance, and Drama Group (MD&D) consists of twenty-five individuals attending IDI and the IDI-supported Kampala City Council Clinics. The group has a repertoire of songs and skits that involve numerous messages of prevention and adherence. So far, they have performed before over 6,000 people in schools, communities, and at IDI.

An HIV positive Ugandan finds hope

Happy Ainomugisha is one of the members of the drama group. Despite her name, she has had a difficult life. Many of her relatives perished in the murder of hundreds of members of a local religious movement, and she moved from southwestern Uganda to Kampala to find employment. After getting to the capital and finding a job in a small pharmacy, she learned that she was HIV-positive and began getting treatment at IDI, where her health stabilized. But when her employer discovered her health status, Happy was fired – only to find out later that her employer was also living with HIV.

MD&D Group performs in the IDI clinic

The MD&D Group performs in the IDI clinic.
(Photography by Cindy Sadler)

Knowing that stigma was the cause of her loss of employment, Happy vowed to do everything
she could to fight stigma. She was selected to join the IDI Music, Dance, and Drama group in May 2008, and says that since she became a member of the group, she has had "no more misery." She goes on, "In the drama group we share life experiences, we chat and laugh together as brothers and sisters, get peer counseling, and educate the public. Through drama I have decided to spend my life supporting and educating others about the dangers of HIV/AIDS. May God bless all the people who support us."

Teaching others through music and dance

The MD&D group will continue to participate in community sensitization exercises in and around Kampala, helping the community to gain a better understanding of how to prevent HIV/AIDS, or of how to live with the disease in a healthier and more positive manner.TOP

 

 



Building a Comprehensive Tuberculosis Program at IDI

Woman and Child

Tuberculosis is the leading cause of death among people with HIV/AIDS in sub-Saharan Africa today. TB is transmitted through the respiratory system, which allows outbreaks to occur frequently in settings where highly susceptible HIV-infected individuals congregate — including hospitals and clinics. To protect this vulnerable population, Accordia’s implementing partner, the Infectious Diseases Institute (IDI), has established a comprehensive TB program involving its Clinical, Research, and Training departments.

An IDI doctor examines an x-ray of a tuberculosis patient. (Charles Steinberg Photography)

A legacy of TB research

Uganda has always been at the forefront of new research on TB. Clinical research on TB in Uganda began during the pre-AIDS era with multi-center trials defining the basic guidelines of short-course chemotherapy. When the AIDS epidemic emerged, Uganda become the site of the first randomized controlled trials of treatment regimens for TB in HIV, and treatment of latent TB infection (preventive therapy). Academic Alliance members Roy Mugerwa, Bob Colebunders, Jerry Ellner, Moses Joloba and Harriet Mayanja-Kizza are all internationally recognized for their research in TB in Uganda, as is IDI Head of Research, Dr. Yuka Manabe.

IDI team leads new charge on TB

There are now exciting new developments in IDI’s TB Research Program. Academic Alliance members Philippa Musoke and Harriet Mayanja-Kizza are leading a public-private collaboration to build clinical trial sites for future TB vaccines in two districts of Uganda. Dr. Bob Colebunders is heading an international consortium to study the pathogenesis of TB immune reconstitution syndrome (IRIS). And Dr. Manabe is working with the Foundation for Innovative Diagnostics (FIND) to compare the promising new technique of LED microscopy, and a new magnetic bead concentration method for the more rapid diagnosis of pulmonary TB.

TB working group establishes best practices in new clinic

To address immediate concerns in the IDI Clinic and develop a best practices model, IDI opened a Tuberculosis Clinic in December 2008 under the direction of Dr. Manabe, IDI Head of Clinical Services Andrew Kambugu, and other members of the recently formed TB Working Group. Suspected or confirmed TB patients are triaged immediately to an outdoor waiting area, with the help of HIV-positive "peer educators." Patients are then evaluated and counseled by medical officers and nurses in an outdoor clinic, greatly reducing the risk of TB transmission. The TB Clinic will soon implement fluorescence smear microscopy and provide TB cultures for all suspected cases. Data captured through the use of newly standardized clinic forms will be an invaluable resource for new research, and IDI is working with the Ugandan National TB and Leprosy Program to reinforce guidelines for the diagnosis and management of suspected TB cases throughout the country.

Training to target medical officers

IDI’s Training Program is also part of this comprehensive approach to overcoming the challenge of TB. A new course on advanced TB management is under development, and will join the training program portfolio this year. The course will target medical officers throughout sub-Saharan Africa, and will include new diagnostic techniques, emerging treatment guidelines, and novel research approaches.

Contributing to the prevention of TB

Treating and preventing tuberculosis is a crucial element in the fight against infectious diseases and IDI is poised to emerge as a national and regional leader in TB clinical management, training, and research. TOP



Summit Convenes Global Health Leaders

TOP: (LEFT) Ugandan First Lady, MP, and Minister of State for Karamoja, the Hon. Janet Museveni and Accordia Chairman Dr. Hank McKinnell. (CENTER) Director of Johns Hopkins
University Center for Global Health, Dr. Tom Quinn; Summit Moderator, Teri Riddle; Professor of the London School of Hygiene & Tropical Medicine, Dr. Keith McAdam. (RIGHT) Director of
Botswana-UPenn Partnership, Dr. Oathokwa Nkomazana.


CENTER: (LEFT) Accordia Vice President, Prof. Nelson Sewankambo. (CENTER) Chief of Party of the ENHANSE Project, Dr. Jerome Mafeni; Associate Director of Corporate Responsibility &
Philanthropy Pfizer Inc, Lebo Taunyane. (RIGHT) Accordia Executive Director Carol Spahn and Vice President of the Abbott Fund Jeff Richardson.


BOTTOM: Panel Participants (left to right): Associate Professor, Makerere University School of Public Health, Dr. Fred Wabwire-Mangen; Deputy Dean, Makerere University School of Public
Health, Dr. William Bazeyo; Co-Founder, Global Health Education Consortium, Dr. Anvar Velji; Board Member, Association of African Business Schools, Jonathon Cook; Professor & Director,
Center for Global Health Clinical Education, Johns Hopkins University, Dr. Robert Bollinger; Director for Capacity Building, AMREF, Peter Ngatia.


(Charles Steinberg Photography) TOP



Become Part of the Equation

Each healthcare professional trained at IDI carries forward the skills learned to train others. The result is a multiplier effect in an equation that maximizes the impact of every dollar donated. Our programs and services reach their full potential through the generous support of our partners and donors. Individual gifts at every level enable Accordia Global Health Foundation to expand our efforts. Together, we will provide access to quality medical care, as well as the tools needed to help Africa move forward independently to a healthier future. Please support our work by making your tax deductible contribution now at www.accordiafoundation.org or by mail to the address below.



CONTACT US

For additional information on Accordia Global Health Foundation and our programs, please contact us at:

Accordia Global Health Foundation
1101 14th Street NW, Suite 801
Washington, DC 20005
phone 202-534-1200
fax 202-534-1220
info@accordiafoundation.org
www.accordiafoundation.org

If you would like to receive this newsletter electronically,
please register at: www.accordiafoundation.org

TOP

Message from Accordia President Warner Greene
READ
Accordia Expands
Board of Directors
READ
IDI Develops
Comprehensive
Tuberculosis Program
READ
Trainee Improves
HIV Care in Local
Community
READ

VIEWPOINT

Accordia Summit Gives
Nigerian Public Health
Leader Hope

Dr. Nasir Sani-Gwarzo, a Medical
Epidemiologist for the Center for Disease Control and Prevention in Nigeria, attended
Accordia’s Infectious Diseases Summit in April. Dr. Sani-Gwarzo is part of a team of healthcare professionals working
with Accordia to strengthen national training capacity in Nigeria. In an interview, he reflected on the importance of building healthcare capacity in Africa.

Why is building healthcare leadership in Africa so important? If you take a look at the African continent and its population, it disproportionately accounts for a high percentage of the global disease burden. This is not due to lack of plans or policies, but to a major disconnect between those policies and the leadership needed to implement them. It is therefore important to stimulate the development of leadership capacities across African health systems, from the healthcare facility to district health administration to the national and regional levels.

All of the stakeholders that the Summit brought together have major roles to play. The open discussions that transpired, as well as the high level of commitment exhibited by the participants, gives me hope. While advocacy is being stepped up within public and private health sectors, efforts should also be made to build a new culture of leadership in pre-service health institutions (e.g. medical schools) and also in high schools and colleges to stimulate young minds on the essence of leadership.

We know that the ‘brain drain’ continues to affect the pool of available talent in Africa. As a public health leader, what keeps you in Africa?

I have a personal commitment to remain in Africa because of the immediate and long-term job satisfaction. When you work in Africa, you immediately see the impact of your work in saving lives and responding to a real need of the people. Nowhere else is the health situation as dire and the reward for providing care so instantaneous.

The most encouraging thing for me is the growing appreciation of the need for action. It is my hope that with improved health leadership, African resources will be better harnessed and channeled
towards permanently improving health outcomes across the continent.
 

WELCOME

Accordia Board of Directors
Welcomes Two New Members

Accordia Global Health Foundation welcomes Dr. Julie Gerberding and Hiromitsu Ogawa to its Board of Directors.

Dr. Gerberding was director of the Centers for Disease Control and Prevention from 2002 to early 2009, after having served as director of the Division of Healthcare Quality Promotion of the National Center for Infectious Diseases. She is a prolific author on subjects related to HIV/AIDS and other infectious diseases. In 2005, Time named her as one of the "Top 100 Innovators of the Year" for her leadership in modernizing the CDC. Forbes Magazine called her one of the 100 most powerful women in the world in 2007 and 2008.

Mr. Ogawa is Managing Partner and founder of Quest Venture Partners. He worked in the container leasing business for over 30 years, during which time he also founded — and still serves as Executive Chairman of the Board for — CAI International. He is an active member of his community  and sits on the Boards of the American Red Cross Bay Area Chapter and the San Francisco Opera. He received the Ernst & Young Northern California Entrepreneur of the Year Award for Business Services in June 2008.

Both of these individuals bring knowledge and skills that will be invaluable to Accordia as it pursues its mission to improve health care in sub-Saharan Africa.

TOP

 
 

RECENT GIFTS

Accordia Acknowledges the Following Major Gifts

The Bill & Melinda Gates Foundation awarded Accordia $12.5 million to conduct a landmark study to identify the most effective and cost-efficient way to prepare healthcare workers in sub-Saharan Africa to treat and prevent infectious diseases.

Pfizer Inc continued its extraordinary support of Accordia and IDI with a $3.6 million grant for core operations.

Dr. Hank McKinnell took the lead in making IDI an enduring institution with an extraordinary gift of $1 million to fund the Sande-McKinnell Executive Director Chair at IDI.

Don and Jennifer Holzworth delivered the first installment of their $250,000 pledge to the Accordia Leadership Fund.

Accordia was awarded a grant of $246,171 to strengthen national training capacity in Nigeria through a public-private partnership between USAID and the ExxonMobil Corporation.

BD delivered its first installment of a two-year, $150,000 grant to support the Laboratory Training Program Scholarship Fund at IDI.

BD awarded Accordia a $127,681 grant to support the BD/PEPFAR Partnership for Laboratory Training.

Warner and Peggy Greene made a $100,000 multi-year commitment to Accordia.

Gary and Fang Bridge donated $50,000 to the Accordia Leadership Fund.

The Serine Bonnist Charitable Fund donated $10,000 in core support for Accordia.

Gary and Lori Cohen donated $10,000 to the Accordia Leadership Fund.

Hiromitsu and Betty Ogawa made a $10,000 gift to the Accordia Leadership Fund.

IDI Training in
Enhanced Malaria and
HIV/AIDS Prevention,
Care & Treatment


3,870

African healthcare workers have been trained to date and are currently working in

27

different African countries.

Countries colored red indicate where African healthcare workers have been trained as of March 31, 2009




NEWS IN BRIEF

President’s Advisory Council:
Accordia Board Member Donald Holzworth was appointed to the President’s Advisory Council on HIV/AIDS (PACHA). PACHA provides the President and the U.S. Department of Health and Human Services expert council on the promotion of services to prevent HIV disease and to advance research on HIV/AIDS.


New Chancellor of UCSF:
Accordia Board Member Susan Desmond-Hellmann was appointed the next Chancellor of the University of California at San Francisco (UCSF) by the UC Board of Regents. Desmond-Hellmann will join the university in her new position in August.


Hamao Umezawav Award:
Academic Alliance Member Allan Ronald has been awarded the prestigious Hamao Umezaway Award for his outstanding contributions in the field of chemotherapy. The award will be presented at the 26th International Congress of Chemotherapy and Infection in June.


San Francisco Event Raises Awareness:
Kathy Burke and Suzanne Mrlik hosted a reception in San Francisco in February to generate greater appreciation of Accordia and its mission. Accordia thanks both individuals for hosting a wonderful evening.


International Council Expands:
Gary Bridge, Robert Norton, and Steven Phillips joined the Accordia International Council in April. The Council was formed in late 2008 to promote wider recognition of Accordia’s work in sub-Saharan Africa. Mr. Bridge, Mr. Norton, and Mr. Phillips are leaders in business and industry and will be effective Accordia ambassadors to their communities.


Senior Vice President Joins Accordia:
Cynthia Sadler has joined the Accordia team as the new Senior Vice President of Fund Development. Ms. Sadler will be focused on promoting greater recognition of Accordia and the work it is doing in Africa.

 

 

ACCORDIA HAS MOVED



Accordia Global Health Foundation Logo



On March 2, 2009 Accordia moved to a new location in downtown Washington DC. Moving forward please use our new contact information listed below.


1101 14th Street NW, Suite 801
Washington, DC 20005
Phone: 202-534-1200
Fax: 202-534-1220

www.accordiafoundation.org



BOARD OF DIRECTORS

Henry A. McKinnell, Jr., PhD
CHAIR
(Retired) Chairman, Pfizer Inc

Warner C. Greene, MD, PhD
PRESIDENT
Director, Gladstone Institute of Virology and Immunology
Nick and Sue Hellman Distinguished Professor of Translational Medicine
Professor of Medicine, Microbiology and Immunology
University of California, San Francisco

Nelson Sewankambo, MD
VICE PRESIDENT
Principal, College of Health Sciences, Makerere University

Robert Mallett
TREASURER
Former Senior Vice President, Worldwide Public Affairs and Policy, Pfizer Inc

Carol Spahn
SECRETARY
Executive Director, Accordia Global Health Foundation

Katherine Burke
Global Health Advocate

Gary M. Cohen
Executive Vice President, BD

Susan Desmond-Hellmann, MD, MPH
President, Product Development, Genentech, Inc.

Joe Feczko, MD
(Retired) Senior Vice President, Chief Medical Officer, Pfizer Inc

Julie L. Gerberding, MD, MPH
Former Director, Centers for Disease
Control and Prevention

Donald A. Holzworth
Chairman, Futures Group International

Hiromitsu Ogawa

Managing Partner and Founder,
Quest Venture Partners

Fred Port
(Retired) Director, Callaway Golf and President, Callaway Golf International

Tommy G. Thompson
Partner, Akin Gump Strauss Hauer & Feld, LLP
Independent Chairman, Deloitte Center for Health Solutions
Former Secretary, US Department of Health and Human Services, 2001–2005, and former Governor, Wisconsin

ACADEMIC ALLIANCE MEMBERS

Michael Scheld, MD
Co-Chair
University of Virginia School of Medicine

Nelson Sewankambo, MBChB, MMed, MSc
Co-Chair
Makerere University Medical School

Robert Colebunders, MD, PhD
University of Antwerp

Jerrold Ellner, MD

UMDNJ-New Jersey Medical School

Warner C. Greene, MD, PhD
Gladstone Institute of Virology and Immunology / University of California, San Francisco

Moses Joloba, MB ChB
Makerere University Medical School

Moses R. Kamya, MB ChB, MMed, MPH
Makerere University Medical School

Elly T. Katabira, MB ChB, FRCP
Makerere University Medical School

Edward Katongole-Mbidde, MB ChB, MMed, MRCP
Uganda Virus Research Institute

Harriet Mayanja-Kizza, MB ChB, MMed (Int Medicine), MS
Makerere University Medical School

Keith McAdam, MB BChir, FRCP, FWACP
London School of Hygiene and Tropical Medicine

Henry A. McKinnell Jr., PhD
Accordia Global Health Foundation

Concepta Merry, FRCPI, MSc, PhD
Trinity College Dublin

Roy D. Mugerwa, MB ChB, MMed
Makerere University Medical School

Philippa Musoke, MD
Makerere University Medical School

Thomas Quinn, MD
John Hopkins University

Allan Ronald, MD
University of Manitoba, Winnipeg

Walter F. Schlech, MD
Dalhousie University

Gisela Schneider, MD, MPH
German Institute for Medical Mission

David Serwadda, MD
Institute of Public Health, Makerere University

David Thomas, MD
Johns Hopkins School of Medicine

Fred Wabwire-Mangen, MB ChB, DTM&H, MPH, PhD
Institute of Public Health, Makerere University